DISARM Act of 2019
USA116th CongressHR-4100| House
| Updated: 7/31/2019
Danny K. Davis
Democratic Representative
Illinois
Cosponsors (23)
Roger Marshall (Republican)Stephanie N. Murphy (Democratic)Lisa Blunt Rochester (Democratic)Chrissy Houlahan (Democratic)Gregory F. Murphy (Republican)Darren Soto (Democratic)Derek Kilmer (Democratic)Brad R. Wenstrup (Republican)Terri A. Sewell (Democratic)Jackie Walorski (Republican)Michael F. Doyle (Democratic)Madeleine Dean (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)Thomas R. Suozzi (Democratic)Jason Smith (Republican)Kenny Marchant (Republican)Josh Harder (Democratic)Brian K. Fitzpatrick (Republican)Susan W. Brooks (Republican)George Holding (Republican)Donna E. Shalala (Democratic)Grace F. Napolitano (Democratic)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 or the DISARM Act of 2019 This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Health
Congressional oversightDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsInfectious and parasitic diseasesMedicare
DISARM Act of 2019
USA116th CongressHR-4100| House
| Updated: 7/31/2019
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 or the DISARM Act of 2019 This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Danny K. Davis
Democratic Representative
Illinois
Cosponsors (23)
Roger Marshall (Republican)Stephanie N. Murphy (Democratic)Lisa Blunt Rochester (Democratic)Chrissy Houlahan (Democratic)Gregory F. Murphy (Republican)Darren Soto (Democratic)Derek Kilmer (Democratic)Brad R. Wenstrup (Republican)Terri A. Sewell (Democratic)Jackie Walorski (Republican)Michael F. Doyle (Democratic)Madeleine Dean (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)Thomas R. Suozzi (Democratic)Jason Smith (Republican)Kenny Marchant (Republican)Josh Harder (Democratic)Brian K. Fitzpatrick (Republican)Susan W. Brooks (Republican)George Holding (Republican)Donna E. Shalala (Democratic)Grace F. Napolitano (Democratic)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional oversightDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsInfectious and parasitic diseasesMedicare